• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
Egyptian Journal of Botany
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 65 (2025)
Volume Volume 64 (2024)
Volume Volume 63 (2023)
Issue Issue 3
Issue Issue 2
Issue Issue 1
Volume Volume 62 (2022)
Volume Volume 61 (2021)
Volume Volume 60 (2020)
Volume Volume 59 (2019)
Volume Volume 58 (2018)
Volume Volume 57 (2017)
Volume Volume 56 (2016)
Volume Volume 55 (2015)
Volume Volume 54 (2014)
Mousa, O., Abd El Hameed, N., ELMehalawy, A., Mohamed, S. (2023). Novel Fibrinolytic Enzyme by Scopulariopsis brevicaulis OS 3456: Production, Characterization, In vitro, and In vivo Activity. Egyptian Journal of Botany, 63(3), 813-830. doi: 10.21608/ejbo.2023.189448.2236
Omnia S. Mousa; Noha M. Abd El Hameed; Adel ELMehalawy; Samar S. Mohamed. "Novel Fibrinolytic Enzyme by Scopulariopsis brevicaulis OS 3456: Production, Characterization, In vitro, and In vivo Activity". Egyptian Journal of Botany, 63, 3, 2023, 813-830. doi: 10.21608/ejbo.2023.189448.2236
Mousa, O., Abd El Hameed, N., ELMehalawy, A., Mohamed, S. (2023). 'Novel Fibrinolytic Enzyme by Scopulariopsis brevicaulis OS 3456: Production, Characterization, In vitro, and In vivo Activity', Egyptian Journal of Botany, 63(3), pp. 813-830. doi: 10.21608/ejbo.2023.189448.2236
Mousa, O., Abd El Hameed, N., ELMehalawy, A., Mohamed, S. Novel Fibrinolytic Enzyme by Scopulariopsis brevicaulis OS 3456: Production, Characterization, In vitro, and In vivo Activity. Egyptian Journal of Botany, 2023; 63(3): 813-830. doi: 10.21608/ejbo.2023.189448.2236

Novel Fibrinolytic Enzyme by Scopulariopsis brevicaulis OS 3456: Production, Characterization, In vitro, and In vivo Activity

Article 9, Volume 63, Issue 3, September 2023, Page 813-830  XML PDF (2.25 MB)
Document Type: Regular issue (Original Article)
DOI: 10.21608/ejbo.2023.189448.2236
View on SCiNiTO View on SCiNiTO
Authors
Omnia S. Mousa email ; Noha M. Abd El Hameed; Adel ELMehalawy; Samar S. Mohamed
Microbiology Department, Faculty of Science, Ain Shams University, 11566, Abbassia, Cairo, Egypt
Abstract
      Fibrinolytic enzyme production from Scopulariopsis brevicaulis OS 3456 isolated from a local soil sample was studied. The enzyme was purified by ammonium sulfate precipitation and gel filtration chromatography using Sephadex G-100, increasing its specific activity to 370 U/mg with a yield of 1.5% and a purification fold of 3.4. The molecular weight of the purified enzyme was 61.5 kDa determined by SDS-PAGE analysis. The optimum temperature of the enzyme was 37oC, and it was stable over a pH range of 5.0–9.0 with maximum stability at pH 7.0. The activity was increased in the presence of ß-mercaptoethanol, Mn2+, Ba2+, triton X-100, and xylene by 137.1, 51.6, 41.4, 37.5, and 23%, respectively. Furthermore, the enzyme activity was inhibited by Cd2+, Al3+, EDTA, PMSF, and acetone. The in vitro thrombolytic activity of the undiluted purified enzyme (370 U/mg) was found to be 100%. Meanwhile, in the cases of 185, 92.5, 46.25, 23.125, and 11.562 U/mg, the clot lysis percentage was 76.8, 67.4, 57.8, 39.5, and 28%, respectively. A carrageenan-induced tail thrombosis model was applied to test the in vivo thrombolytic activity of the enzyme. The result indicated no obvious thrombus in the tails of mice treated with the tested enzyme (370 U/mg). However, when the enzyme was diluted, its thrombolytic activity decreased gradually. All these results explore the promising thrombolytic activity of the extracted fibrinolytic enzyme. Hence, more purification steps and more experimental animal studies are required in the future for its use as a commercial drug.
Keywords
Fibrin; Fibrinolytic enzyme; In vitro activity; In vivo activity; Scopulariopsis sp; Thrombosis
Statistics
Article View: 414
PDF Download: 754
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.